|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. B
|
||||||||||||||||
 |
 |
Page 89 |
 |
 |
 |
|
| ||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 89
A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA’s Bioastronautics Roadmap
B
Methods
The committee developed this interim report and arrived at conclusions and recommendations regarding the strengths and weaknesses of the Bioastronautics Roadmap (BR) during a 13-month period from April 2004 to May 2005. During this time, the committee held four data-gathering sessions; made one site visit to the Johnson Space Center in Houston, Texas; and met in closed session seven times to deliberate. Agendas for the open, data-gathering sessions of these meetings are included in this appendix.
OCR for page 90
A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA’s Bioastronautics Roadmap
INSTITUTE OF MEDICINE
AGENDA
Committee on Aerospace Medicine and Medicine in Extreme Environments
and
Committee on Review of NASA’s Bioastronautics
Critical Path Roadmap
Keck Building
500 5th Street, NW
Washington, DC
Room 110
Monday, April 12, 2004
CLOSED SESSION
(committee and staff only)
8:00 a.m.–12:00 p.m.
OPEN SESSION
12:00 p.m.
Lunch
1:00 p.m.
Request for a review of the Bioastronautics Critical Path Roadmap (BCPR)
Richard Williams, M.D., Chief Health and Medical Officer, NASA
1:10 p.m.
Overview of the Bioastronautics Critical Path Roadmap
NASA presenters: Guy Fogleman, director of bioastronautics research, Office of Biological and Physical Research; Howard Ross, acting deputy associate administrator for science, Office of Biological and Physical Research; Marc Shepanek, deputy chief, Medicine of Extreme Environments, NASA; Frank Sulzman, manager, Space Radiation Health Project
1:20 p.m.
How the Bioastronautics Critical Path Roadmap captures the critical risks and key research and technology issues for risk reduction, management, and informed decision making
OCR for page 91
A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA’s Bioastronautics Roadmap
1:40 p.m.
The Bioastronautics Critical Path Roadmap’s method and expression of risk assessment for medical decision making and the BCPR communication of these methods for different mission scenarios
2:20 p.m.
Types of risks and impacts of risk as expressed in the Bioastronautics Critical Path Roadmap
3:00 p.m.
Break
3:30 p.m.
Categories of critical research issues and metrics used in the Bioastronautics Critical Path Roadmap
4:10 p.m.
Efficiency and technology issues in the Bioastronautics Critical Path Roadmap
4:50 p.m.
Plenary discussion
Led by David Longnecker, M.D.
5:30 p.m.
Adjourn to reception and dinner with invited guests
Location: third floor atrium
Tuesday, April 13, 2004
OPEN SESSION
8:00 a.m.
Continental breakfast
8:30 a.m.
Welcoming remarks
David Longnecker, M.D.
8:45 a.m.
Overview of related work by the National Academies
9:00 a.m.
Space Studies Board/ASEB
9:30 a.m.
CAMMEE
10:00 a.m.
Break
CLOSED SESSION
(committee and staff only)
10:15 a.m.–3:30 p.m.
OCR for page 92
A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA’s Bioastronautics Roadmap
INSTITUTE OF MEDICINE
AGENDA
Committee on Review of NASA’s Bioastronautics
Critical Path Roadmap
Keck Building
500 5th Street, NW
Washington, DC
Room 204
Wednesday, June 9, 2004
OPEN SESSION
9:00 a.m.
Welcome and overview of day’s agenda
David Longnecker, M.D., and Lisa Vandemark, Ph.D.
9:15 a.m.
Briefings related to the review of the Bioastronautics Critical Path Roadmap
NASA presenters: Lauren Leveton, Bioastronautics Science Management Team, NASA; Holly Patton, Aerospace Technologist, NASA; David Tomko, Lead Scientist, Biomedical Program, BASA Bioastronautics Research Division; Guy Fogleman, Director of Bioastronautics Research, Office of Biological and Physical Research; Frank Sulzman, Manager, Space Radiation Health Project
12:00 p.m.
Lunch
1:00 p.m.
Bone loss and countermeasures: historical perspectives and new in-flight clinical studies
Jay Shapiro, M.D., Uniformed Services University of the Health Sciences
2:00 p.m.
Harmonization of crew living module and extravehicular pressure suit atmospheric constituents and pressures
Bruce McCandless, M.S., M.B.A., Lockheed Martin
3:00 p.m.
Break
3:30 p.m.
An overview of space biology from cells to humans
David Klaus, Ph.D., University of Colorado, Boulder
4:30 p.m.
Plenary discussion
Led by David Longnecker, M.D.
5:30 p.m.
Adjourn
OCR for page 93
A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA’s Bioastronautics Roadmap
Thursday, June 10, 2004
CLOSED SESSION
(committee and staff only)
8:30 a.m.–3:00 p.m.
INSTITUTE OF MEDICINE
AGENDA
Committee on Review of NASA’s Bioastronautics
Critical Path Roadmap
Keck Building
500 5th Street, NW
Washington, DC
Room 201
Monday, August 2, 2004
OPEN SESSION
9:00 a.m.
Welcome, introductions, and overview of day’s agenda
David Longnecker, M.D., and Lisa Vandemark, Ph.D.
9:20 a.m.
Briefings related to the review of the Bioastronautics Critical Path Roadmap
Richard Williams, M.D.
10:30 a.m.
Break
11:00 a.m.
Briefings related to the review of the Bioastronautics Critical Path Roadmap
NASA presenters via videoconference from Johnson Space Center: Guy Fogleman, Director of Bioastronautics Research, Office of Biological and Physical Research; Marc Shepanek, Deputy Chief, Medicine of Extreme Environments, NASA; Desmond Lugg, Chief, Medicine of Extreme Environments, Office of the Chief Medical Officer
11:30 a.m.
Question-and-answer discussion
David Longnecker, M.D., Moderator
12:00 p.m.
Lunch
OCR for page 94
A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA’s Bioastronautics Roadmap
1:00 p.m.
Advanced life support issues
Brian Dunaway, Boeing Corporation
CLOSED SESSION
(committee and staff only)
2:30 p.m.–5:30 p.m.
Tuesday, August 3, 2004
CLOSED SESSION
(committee and staff only)
8:30 a.m.–3:00 p.m.
INSTITUTE OF MEDICINE
AGENDA
Committee on Review of NASA’s Bioastronautics
Critical Path Roadmap
National Academy of Sciences Building
2101 Constitution Avenue, NW
Washington, DC
Lecture Room
Monday, January 31, 2005
OPEN SESSION
9:00 a.m.
Welcome and introductions
David E. Longnecker, M.D., Chair
9:20 a.m.
Overview of the day’s agenda
Lisa M. Vandemark, Ph.D., Study Director
9:30 a.m.
Guest presentations
Admiral Walter Cantrell, NASA Headquarters; Joseph Genovese, Hamilton Sunstrand; Joseph Fuller, Futron Corporation
12:00 p.m.
Lunch
OCR for page 95
A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA’s Bioastronautics Roadmap
1:00 p.m.
Guest presentations
Geoffrey McIntyre, Federal Aviation Administration; Michael Gernhardt, NASA Johnson Space Center; Alan Feiveson, NASA Johnson Space Center (via phone conference); William Stone, Stone Aerospace
3:15 p.m.
Break
4:00 p.m.
Overview of the new Bioastronautics Roadmap
Lauren Leveton, Ph.D., NASA Headquarters
4:30 p.m.
Plenary discussion
Led by David Longnecker, M.D.
5:30 p.m.
Adjourn
Tuesday, February 1, 2005
CLOSED SESSION
(committee and staff only)
OCR for page 96
A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA’s Bioastronautics Roadmap
This page intentionally left blank.
Representative terms from entire chapter:
critical path